Monocyte-derived dendritic cells from cirrhotic patients retain similar capacity for maturation/activation and antigen presentation as those from healthy subjects

•CD14+ monocytes from cirrhotic patients displayed enhanced M1 and M2 polarization.•MoDC derived from cirrhotic CD14+ monocytes display normal co-stimulation markers.•Antigen-presentation capacity of MoDC from cirrhotic and healthy donors were similar. Few studies have investigated the impact of liv...

Full description

Saved in:
Bibliographic Details
Published inCellular immunology Vol. 295; no. 1; pp. 36 - 45
Main Authors Tanoue, Shiroh, Chang, Li-Yuan, Li, Yonghai, Kaplan, David E.
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Inc 01.05.2015
Subjects
Online AccessGet full text

Cover

Loading…
Abstract •CD14+ monocytes from cirrhotic patients displayed enhanced M1 and M2 polarization.•MoDC derived from cirrhotic CD14+ monocytes display normal co-stimulation markers.•Antigen-presentation capacity of MoDC from cirrhotic and healthy donors were similar. Few studies have investigated the impact of liver cirrhosis on dendritic cell function. The purpose of this study was to compare the activation and antigen-presentation capacity of monocyte-derived dendritic cells (MoDC) from cirrhotic patients (CIR) relative to healthy donors (HD). MoDC from CIR and HD were matured, phenotyped, irradiated and pulsed with 15mer peptides for two hepatocellular carcinoma-related antigens, alphafetoprotein and glypican-3, then co-cultured with autologous T-cells. Expanded T-cells were evaluated by interferon-gamma ELISPOT and intracellular staining. 15 CIR and 7 HD were studied. While CD14+ monocytes from CIR displayed enhanced M2 polarization, under MoDC-polarizing conditions, we identified no significant difference between HD and CIR in maturation-induced upregulation of co-stimulation markers. Furthermore, no significant differences were observed between CIR and HD in subsequent expansion of tumor antigen-specific IFNγ+ T-cells. Conclusion: MoDCs isolated from cirrhotic individuals retain similar capacity for in vitro activation, maturation and antigen-presentation as those from healthy donors.
AbstractList Few studies have investigated the impact of liver cirrhosis on dendritic cell function. The purpose of this study was to compare the activation and antigen-presentation capacity of monocyte-derived dendritic cells (MoDC) from cirrhotic patients (CIR) relative to healthy donors (HD). MoDC from CIR and HD were matured, phenotyped, irradiated and pulsed with 15mer peptides for two hepatocellular carcinoma-related antigens, alphafetoprotein and glypican-3, then co-cultured with autologous T-cells. Expanded T-cells were evaluated by interferon-gamma ELISPOT and intracellular staining. 15 CIR and 7 HD were studied. While CD14+ monocytes from CIR displayed enhanced M2 polarization, under MoDC-polarizing conditions, we identified no significant difference between HD and CIR in maturation-induced upregulation of co-stimulation markers. Furthermore, no significant differences were observed between CIR and HD in subsequent expansion of tumor antigen-specific IFNγ+ T-cells.UNLABELLEDFew studies have investigated the impact of liver cirrhosis on dendritic cell function. The purpose of this study was to compare the activation and antigen-presentation capacity of monocyte-derived dendritic cells (MoDC) from cirrhotic patients (CIR) relative to healthy donors (HD). MoDC from CIR and HD were matured, phenotyped, irradiated and pulsed with 15mer peptides for two hepatocellular carcinoma-related antigens, alphafetoprotein and glypican-3, then co-cultured with autologous T-cells. Expanded T-cells were evaluated by interferon-gamma ELISPOT and intracellular staining. 15 CIR and 7 HD were studied. While CD14+ monocytes from CIR displayed enhanced M2 polarization, under MoDC-polarizing conditions, we identified no significant difference between HD and CIR in maturation-induced upregulation of co-stimulation markers. Furthermore, no significant differences were observed between CIR and HD in subsequent expansion of tumor antigen-specific IFNγ+ T-cells.MoDCs isolated from cirrhotic individuals retain similar capacity for in vitro activation, maturation and antigen-presentation as those from healthy donors.CONCLUSIONMoDCs isolated from cirrhotic individuals retain similar capacity for in vitro activation, maturation and antigen-presentation as those from healthy donors.
Few studies have investigated the impact of liver cirrhosis on dendritic cell function. The purpose of this study was to compare the activation and antigen-presentation capacity of monocyte-derived dendritic cells (MoDC) from cirrhotic patients (CIR) relative to healthy donors (HD). MoDC from CIR and HD were matured, phenotyped, irradiated and pulsed with 15mer peptides for two hepatocellular carcinoma-related antigens, alphafetoprotein and glypican-3, then co-cultured with autologous T-cells. Expanded T-cells were evaluated by interferon-gamma ELISPOT and intracellular staining. 15 CIR and 7 HD were studied. While CD14+ monocytes from CIR displayed enhanced M2 polarization, under MoDC-polarizing conditions, we identified no significant difference between HD and CIR in maturation-induced upregulation of co-stimulation markers. Furthermore, no significant differences were observed between CIR and HD in subsequent expansion of tumor antigen-specific IFNγ+ T-cells.
Few studies have investigated the impact of liver cirrhosis on dendritic cell function. The purpose of this study was to compare the activation and antigen-presentation capacity of monocyte-derived dendritic cells (MoDC) from cirrhotic patients (CIR) relative to healthy donors (HD). MoDC from CIR and HD were matured, phenotyped, irradiated and pulsed with 15mer peptides for two hepatocellular carcinoma-related antigens, alphafetoprotein and glypican-3, then co-cultured with autologous T-cells. Expanded T-cells were evaluated by interferon-gamma ELISPOT and intracellular staining. 15 CIR and 7 HD were studied. While CD14+ monocytes from CIR displayed enhanced M2 polarization, under MoDC-polarizing conditions, we identified no significant difference between HD and CIR in maturation-induced upregulation of co-stimulation markers. Furthermore, no significant differences were observed between CIR and HD in subsequent expansion of tumor antigen-specific IFN gamma + T-cells. Conclusion: MoDCs isolated from cirrhotic individuals retain similar capacity for in vitro activation, maturation and antigen-presentation as those from healthy donors.
•CD14+ monocytes from cirrhotic patients displayed enhanced M1 and M2 polarization.•MoDC derived from cirrhotic CD14+ monocytes display normal co-stimulation markers.•Antigen-presentation capacity of MoDC from cirrhotic and healthy donors were similar. Few studies have investigated the impact of liver cirrhosis on dendritic cell function. The purpose of this study was to compare the activation and antigen-presentation capacity of monocyte-derived dendritic cells (MoDC) from cirrhotic patients (CIR) relative to healthy donors (HD). MoDC from CIR and HD were matured, phenotyped, irradiated and pulsed with 15mer peptides for two hepatocellular carcinoma-related antigens, alphafetoprotein and glypican-3, then co-cultured with autologous T-cells. Expanded T-cells were evaluated by interferon-gamma ELISPOT and intracellular staining. 15 CIR and 7 HD were studied. While CD14+ monocytes from CIR displayed enhanced M2 polarization, under MoDC-polarizing conditions, we identified no significant difference between HD and CIR in maturation-induced upregulation of co-stimulation markers. Furthermore, no significant differences were observed between CIR and HD in subsequent expansion of tumor antigen-specific IFNγ+ T-cells. Conclusion: MoDCs isolated from cirrhotic individuals retain similar capacity for in vitro activation, maturation and antigen-presentation as those from healthy donors.
Few studies have investigated the impact of liver cirrhosis on dendritic cell function. The purpose of this study was to compare the activation and antigen-presentation capacity of monocyte-derived dendritic cells (MoDC) from cirrhotic patients (CIR) relative to healthy donors (HD). MoDC from CIR and HD were matured, phenotyped, irradiated and pulsed with 15mer peptides for two hepatocellular carcinoma-related antigens, alphafetoprotein and glypican-3, then co-cultured with autologous T-cells. Expanded T-cells were evaluated by interferon-gamma ELISPOT and intracellular staining. 15 CIR and 7 HD were studied. While CD14+ monocytes from CIR displayed enhanced M2 polarization, under MoDC-polarizing conditions, we identified no significant difference between HD and CIR in maturation-induced upregulation of co-stimulation markers. Furthermore, no significant differences were observed between CIR and HD in subsequent expansion of tumor antigen-specific IFNγ+ T-cells. MoDCs isolated from cirrhotic individuals retain similar capacity for in vitro activation, maturation and antigen-presentation as those from healthy donors.
Author Li, Yonghai
Tanoue, Shiroh
Chang, Li-Yuan
Kaplan, David E.
Author_xml – sequence: 1
  givenname: Shiroh
  surname: Tanoue
  fullname: Tanoue, Shiroh
– sequence: 2
  givenname: Li-Yuan
  surname: Chang
  fullname: Chang, Li-Yuan
– sequence: 3
  givenname: Yonghai
  surname: Li
  fullname: Li, Yonghai
– sequence: 4
  givenname: David E.
  surname: Kaplan
  fullname: Kaplan, David E.
  email: dakaplan@mail.med.upenn.edu
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25734547$$D View this record in MEDLINE/PubMed
BookMark eNqFUk2P0zAQtdAitrvwE0A-ckl37CROIiQQWvElLeICZ8uxJxtXiR1st1L_Dr8Ud9tFwKUHy9b4zZunN--KXDjvkJCXDNYMmLjZrDVOk53nNQdWr4GvAdonZMWgg4IzUV6QFeRS0TZVd0muYtwAMFZ18Ixc8ropq7pqVuTXV--83icsDAa7Q0MNOhNsspoeBkQ6BD9TbUMY_aG4qGTRpUgDJmUdjXa2kwpUq0Vpm_Z08IHOKm1DBnp3o3Syu4cnVc7kk-w9OroEjJnm9BFpGn3E46wR1ZTGPY3bfoM6xefk6aCmiC9O9zX58fHD99vPxd23T19u398VugZIhdAlM6CrQRuhBigVF6JTfNBCGNEwMCX2PW8gu1dyjag5axlreuhq6M0wlNfk7ZF32fYzGp3lBTXJJdhZhb30ysp_f5wd5b3fyaqC7CXLBK9PBMH_3GJMcrbxYKJy6LdRsqbkLSvbbP5ZqGgq0XZdU2foq79l_dHzuMMMeHME6OBjDDjIvIcHY7NKO0kG8pAYuZGnxMhDYiRwmeORu-v_uh8HnOt7d-zDvJKdxSCjzsHQaGzIW5PG2zMMvwHZtuQG
CitedBy_id crossref_primary_10_1002_hep_28419
crossref_primary_10_1016_j_jhep_2020_03_027
crossref_primary_10_1038_s41575_021_00520_7
crossref_primary_10_1080_1061186X_2024_2347365
Cites_doi 10.1158/1078-0432.CCR-04-0502
10.1016/j.jim.2005.05.010
10.1016/j.smim.2009.05.010
10.4049/jimmunol.160.3.1139
10.1186/1471-2407-7-119
10.4049/jimmunol.1201271
10.1038/mt.2008.77
10.1016/j.jhep.2004.09.014
10.4049/jimmunol.179.7.4307
10.1002/hep.22626
10.4049/jimmunol.1201008
10.1111/j.1365-2893.2007.00934.x
10.4049/jimmunol.162.9.5584
10.1128/JVI.02080-07
10.1016/S1470-2045(01)00486-7
10.1111/j.1365-2249.2010.04246.x
10.4161/hv.22473
10.1111/j.1349-7006.2004.tb03248.x
10.4049/jimmunol.179.6.3515
10.1146/annurev.immunol.23.021704.115839
10.3748/wjg.v17.i48.5260
10.1002/ijc.28372
10.1016/S0168-8278(99)80231-1
10.1093/intimm/dxp077
10.1155/2011/249281
10.1089/vim.2014.0056
10.4049/jimmunol.0900187
10.1182/blood.V97.10.3171
10.1002/hep.21176
10.1371/journal.pone.0055264
10.4049/jimmunol.170.8.4069
10.1007/s00262-007-0337-9
10.1182/blood-2003-04-1339
10.1053/gast.2001.21212
10.1016/j.imbio.2014.07.020
10.1007/s00262-002-0360-9
10.1016/j.jim.2005.11.023
10.1111/j.1530-0277.2003.tb04431.x
10.1016/j.cellimm.2009.09.003
10.1097/01.ALC.0000127104.80398.9B
10.1016/j.yexmp.2014.04.003
10.1128/JVI.77.20.10862-10871.2003
10.1111/liv.12284
10.4049/jimmunol.179.10.7137
10.1159/000341697
10.1016/j.clim.2011.02.014
10.3892/ijo.2012.1626
10.1038/nature10673
10.1111/j.1742-1241.2011.02814.x
10.1158/1078-0432.CCR-05-2856
10.1053/j.gastro.2013.10.031
ContentType Journal Article
Copyright 2015
Published by Elsevier Inc.
2015 Published by Elsevier Inc. 2015
Copyright_xml – notice: 2015
– notice: Published by Elsevier Inc.
– notice: 2015 Published by Elsevier Inc. 2015
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7T5
H94
5PM
DOI 10.1016/j.cellimm.2015.02.008
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Immunology Abstracts
AIDS and Cancer Research Abstracts
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
AIDS and Cancer Research Abstracts
Immunology Abstracts
DatabaseTitleList MEDLINE - Academic

AIDS and Cancer Research Abstracts

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1090-2163
EndPage 45
ExternalDocumentID PMC4405471
25734547
10_1016_j_cellimm_2015_02_008
S0008874915000428
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: Pennsylvania Commonwealth Universal Research Endowment
– fundername: NIH
  grantid: R01 CA166111
  funderid: http://dx.doi.org/10.13039/100000002
– fundername: CSRD VA
  grantid: I01 CX000981
– fundername: NIDDK NIH HHS
  grantid: P30 DK050306
– fundername: NCI NIH HHS
  grantid: R01 CA166111
GroupedDBID ---
--K
--M
-~X
.55
.GJ
.~1
0R~
1B1
1KJ
1RT
1~.
1~5
29B
3O-
4.4
457
4G.
53G
5GY
5RE
5VS
6J9
7-5
71M
8P~
9JM
AAAJQ
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AARKO
AAXUO
ABFRF
ABGSF
ABJNI
ABMAC
ABUDA
ABXDB
ACDAQ
ACGFO
ACGFS
ACNCT
ACRLP
ADBBV
ADEZE
ADFGL
ADMUD
ADUVX
AEBSH
AEFWE
AEHWI
AEKER
AENEX
AFKWA
AFTJW
AFXIZ
AGEKW
AGHFR
AGRDE
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJOXV
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
CAG
CJTIS
COF
CS3
DM4
DU5
EBS
EFBJH
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HLW
HMG
HVGLF
HX~
HZ~
IHE
J1W
J5H
K-O
KOM
L7B
LG5
LUGTX
LX2
LZ5
M41
MO0
N9A
O-L
O9-
OAUVE
OHT
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SBG
SDF
SDG
SDP
SES
SEW
SIN
SPCBC
SSI
SSU
SSZ
T5K
UNMZH
WH7
WUQ
X7M
XOL
XPP
Y6R
YYP
ZGI
ZMT
~G-
AATTM
AAXKI
AAYWO
AAYXX
ABWVN
ACRPL
ACVFH
ADCNI
ADNMO
AEIPS
AEUPX
AFJKZ
AFPUW
AGCQF
AGQPQ
AGRNS
AIGII
AIIUN
AKBMS
AKYEP
ANKPU
APXCP
BNPGV
CITATION
SSH
CGR
CUY
CVF
ECM
EFKBS
EIF
NPM
7X8
7T5
H94
5PM
ID FETCH-LOGICAL-c500t-6c31d0c4fcd6af03a2669a2fc66d6710d3ebb27010132ceec218117b0950bdff3
IEDL.DBID .~1
ISSN 0008-8749
1090-2163
IngestDate Thu Aug 21 13:52:18 EDT 2025
Fri Jul 11 03:37:49 EDT 2025
Fri Jul 11 00:01:57 EDT 2025
Mon Jul 21 05:58:21 EDT 2025
Thu Apr 24 23:12:46 EDT 2025
Tue Jul 01 01:48:07 EDT 2025
Tue Jul 23 07:56:02 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Human
Dendritic cell
Monocyte
MoDC
M1 macrophage
HCC
AFP
CIR
PBMC
Cirrhosis
M2 macrophage
GPC3
HCV
Glypican-3
HD
Hepatitis C
Language English
License Published by Elsevier Inc.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c500t-6c31d0c4fcd6af03a2669a2fc66d6710d3ebb27010132ceec218117b0950bdff3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://doi.org/10.1016/j.cellimm.2015.02.008
PMID 25734547
PQID 1674689975
PQPubID 23479
PageCount 10
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4405471
proquest_miscellaneous_1732813857
proquest_miscellaneous_1674689975
pubmed_primary_25734547
crossref_citationtrail_10_1016_j_cellimm_2015_02_008
crossref_primary_10_1016_j_cellimm_2015_02_008
elsevier_sciencedirect_doi_10_1016_j_cellimm_2015_02_008
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2015-05-01
PublicationDateYYYYMMDD 2015-05-01
PublicationDate_xml – month: 05
  year: 2015
  text: 2015-05-01
  day: 01
PublicationDecade 2010
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Cellular immunology
PublicationTitleAlternate Cell Immunol
PublicationYear 2015
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Bain, Fatmi, Zoulim, Zarski, Trepo, Inchauspe (b0165) 2001; 120
Sangiovanni, Prati, Fasani, Ronchi, Romeo, Manini, Del Ninno, Morabito, Colombo (b0010) 2006; 43
Y. Xu, H. Li, R. L. Gao, O. Adeyemo, M. Itkin and D. E. Kaplan, Expansion of interferon-gamma-producing multifunctional CD4+ T-cells and dysfunctional CD8+ T-cells by glypican-3 peptide library in hepatocellular carcinoma patients, Clin Immunol. In press (2011).
Van Gulck, Vanham, Heyndrickx, Coppens, Vereecken, Atkinson, Florence, Kint, Berneman, Van Tendeloo (b0220) 2008; 82
Pen, De Keersmaecker, Maenhout, Van Nuffel, Heirman, Corthals, Escors, Bonehill, Thielemans, Breckpot, Aerts (b0245) 2013; 191
Butterfield, Ribas, Potter, Economou (b0045) 2007; 56
Zhong, Ma, Wu, Zhao, Yuan, Wu, Zhang, Huang, You, Li (b0060) 2012; 66
Kakazu, Kanno, Ueno, Shimosegawa (b0215) 2007; 179
Kayashima, Toshima, Okano, Taketomi, Harada, Yamashita, Tomita, Shirabe, Maehara (b0230) 2010; 185
Szabo, Catalano, White, Mandrekar (b0200) 2004; 28
Butterfield, Ribas, Dissette, Lee, Yang, De la Rocha, Duran, Hernandez, Seja, Potter, McBride, Finn, Glaspy, Economou (b0015) 2006; 12
Jenkins, Perona-Wright, Worsley, Ishii, MacDonald (b0115) 2007; 179
Iwashita, Tahara, Goto, Sasaki, Kai, Seike, Chen, Kawano, Kitano (b0025) 2003; 52
Sun, Fink (b0130) 2007; 179
Mellman, Coukos, Dranoff (b0035) 2011; 480
Dauer, Schad, Herten, Junkmann, Bauer, Kiefl, Endres, Eigler (b0105) 2005; 302
Ma, Clark (b0135) 2009; 21
Ho, Nguyen, Wolfl, Kuball, Greenberg (b0205) 2006; 310
Jarnjak-Jankovic, Hammerstad, Saeboe-Larssen, Kvalheim, Gaudernack (b0210) 2007; 7
Agrawal, Samrat, Agrawal, Tyrrell, Kumar (b0195) 2014
Nakamoto, Mizukoshi, Kitahara, Arihara, Sakai, Kakinoki, Fujita, Marukawa, Arai, Yamashita, Mukaida, Matsushima, Matsui, Kaneko (b0070) 2011; 163
Schmidt, Neumann-Haefelin, Thimme (b0090) 2012; 30
Kvistborg, Boegh, Pedersen, Claesson, Zocca (b0095) 2009; 260
A. Vogt, E. Sievers, V. Lukacs-Kornek, G. Decker, E. Raskopf, N. Meumann, H. Buning, T. Sauerbruch, C.P. Strassburg, I.G. Schmidt-Wolf and M.A. Gonzalez-Carmona, Improving immunotherapy of hepatocellular carcinoma (HCC) using dendritic cells (DC) engineered to express IL-12 in vivo, Liver Int. (2013).
Nobuoka, Yoshikawa, Sawada, Fujiwara, Nakatsura (b0055) 2013; 9
Barnes, Salio, Cerundolo, Francesco, Pardoll, Klenerman, Cox (b0185) 2008; 15
Shang, Chen, Zhang, Pang, Qiao, Peng, Qin, Fei, Mei, Leng, Gnjatic, Ritter, Simpson, Old, Chen (b0040) 2004; 10
Bray, Vujanovic, Butterfield (b0145) 2011; 2011
Szabo, Gogolak, Pazmandi, Kis-Toth, Riedl, Wizel, Lingnau, Bacsi, Rethi, Rajnavolgyi (b0240) 2013; 8
Ju, Ju, Ge, Qiu, Lu, Qiu, Fu, Liu, Wang, Hu, Shu, Zhang (b0120) 2009; 21
Watts (b0125) 2005; 23
Dolganiuc, Kodys, Kopasz, Marshall, Mandrekar, Szabo (b0170) 2003; 27
Bonehill, Tuyaerts, Van Nuffel, Heirman, Bos, Fostier, Neyns, Thielemans (b0250) 2008; 16
Wijesundera, Izawa, Tennakoon, Murakami, Golbar, Katou-Ichikawa, Tanaka, Kuwamura, Yamate (b0260) 2014; 96
Parkin (b0005) 2001; 2
Piccioli, Tavarini, Nuti, Colombatto, Brunetto, Bonino, Ciccorossi, Zorat, Pozzato, Comar, Abrignani, Wack (b0180) 2005; 42
Kanto, Hayashi, Takehara, Tatsumi, Kuzushita, Ito, Sasaki, Kasahara, Hori (b0160) 1999; 162
Qiu, Xu, Yun, Wang, Zhang, Meng, Ou-Yang, Yun (b0065) 2011; 17
Dauer, Obermaier, Herten, Haerle, Pohl, Rothenfusser, Schnurr, Endres, Eigler (b0100) 2003; 170
Auffermann-Gretzinger, Keeffe, Levy (b0150) 2001; 97
Bak, Barnkob, Bai, Higham, Wittrup, Chen (b0110) 2012; 189
Tada, Abe, Hirooka, Ikeda, Hiasa, Lee, Jung, Lee, Lee, Bae, Onji (b0020) 2012; 41
Sarobe, Lasarte, Zabaleta, Arribillaga, Arina, Melero, Borras-Cuesta, Prieto (b0155) 2003; 77
Cui, Wang, Zhao, Jin, Wang, Niu, Terunuma, He, Li (b0050) 2014; 134
Ninomiya, Akbar, Masumoto, Horiike, Onji (b0080) 1999; 31
Ikeda, Chamoto, Tsuji, Suzuki, Wakita, Takeshima, Nishimura (b0030) 2004; 95
Goode, Warburton, Gelson, Watson (b0255) 2013; 145
Hatipoglu, Ercan, Acilan, Basalp, Durali, Baykal (b0190) 2014
Palmer, Midgley, Mirza, Torr, Ahmed, Steele, Steven, Kerr, Young, Adams (b0075) 2009; 49
Sun, Wang, Zhang (b0140) 2006; 3
Tuting, Wilson, Martin, Kasamon, Rowles, Ma, Slingluff, Wagner, van der Bruggen, Baar, Lotze, Storkus (b0235) 1998; 160
Longman, Talal, Jacobson, Albert, Rice (b0175) 2004; 103
Cui (10.1016/j.cellimm.2015.02.008_b0050) 2014; 134
Dolganiuc (10.1016/j.cellimm.2015.02.008_b0170) 2003; 27
Goode (10.1016/j.cellimm.2015.02.008_b0255) 2013; 145
Watts (10.1016/j.cellimm.2015.02.008_b0125) 2005; 23
Barnes (10.1016/j.cellimm.2015.02.008_b0185) 2008; 15
Tuting (10.1016/j.cellimm.2015.02.008_b0235) 1998; 160
Jarnjak-Jankovic (10.1016/j.cellimm.2015.02.008_b0210) 2007; 7
Ma (10.1016/j.cellimm.2015.02.008_b0135) 2009; 21
Dauer (10.1016/j.cellimm.2015.02.008_b0100) 2003; 170
Mellman (10.1016/j.cellimm.2015.02.008_b0035) 2011; 480
Sarobe (10.1016/j.cellimm.2015.02.008_b0155) 2003; 77
Zhong (10.1016/j.cellimm.2015.02.008_b0060) 2012; 66
Longman (10.1016/j.cellimm.2015.02.008_b0175) 2004; 103
10.1016/j.cellimm.2015.02.008_b0085
Sun (10.1016/j.cellimm.2015.02.008_b0130) 2007; 179
Dauer (10.1016/j.cellimm.2015.02.008_b0105) 2005; 302
Nakamoto (10.1016/j.cellimm.2015.02.008_b0070) 2011; 163
Auffermann-Gretzinger (10.1016/j.cellimm.2015.02.008_b0150) 2001; 97
Bonehill (10.1016/j.cellimm.2015.02.008_b0250) 2008; 16
Iwashita (10.1016/j.cellimm.2015.02.008_b0025) 2003; 52
Pen (10.1016/j.cellimm.2015.02.008_b0245) 2013; 191
Nobuoka (10.1016/j.cellimm.2015.02.008_b0055) 2013; 9
Van Gulck (10.1016/j.cellimm.2015.02.008_b0220) 2008; 82
Ninomiya (10.1016/j.cellimm.2015.02.008_b0080) 1999; 31
Schmidt (10.1016/j.cellimm.2015.02.008_b0090) 2012; 30
Palmer (10.1016/j.cellimm.2015.02.008_b0075) 2009; 49
Sangiovanni (10.1016/j.cellimm.2015.02.008_b0010) 2006; 43
Butterfield (10.1016/j.cellimm.2015.02.008_b0015) 2006; 12
Kvistborg (10.1016/j.cellimm.2015.02.008_b0095) 2009; 260
Agrawal (10.1016/j.cellimm.2015.02.008_b0195) 2014
Wijesundera (10.1016/j.cellimm.2015.02.008_b0260) 2014; 96
Ikeda (10.1016/j.cellimm.2015.02.008_b0030) 2004; 95
Sun (10.1016/j.cellimm.2015.02.008_b0140) 2006; 3
Ho (10.1016/j.cellimm.2015.02.008_b0205) 2006; 310
Piccioli (10.1016/j.cellimm.2015.02.008_b0180) 2005; 42
Bray (10.1016/j.cellimm.2015.02.008_b0145) 2011; 2011
Parkin (10.1016/j.cellimm.2015.02.008_b0005) 2001; 2
Bain (10.1016/j.cellimm.2015.02.008_b0165) 2001; 120
Kayashima (10.1016/j.cellimm.2015.02.008_b0230) 2010; 185
Shang (10.1016/j.cellimm.2015.02.008_b0040) 2004; 10
Bak (10.1016/j.cellimm.2015.02.008_b0110) 2012; 189
Butterfield (10.1016/j.cellimm.2015.02.008_b0045) 2007; 56
Szabo (10.1016/j.cellimm.2015.02.008_b0200) 2004; 28
10.1016/j.cellimm.2015.02.008_b0225
Kanto (10.1016/j.cellimm.2015.02.008_b0160) 1999; 162
Kakazu (10.1016/j.cellimm.2015.02.008_b0215) 2007; 179
Jenkins (10.1016/j.cellimm.2015.02.008_b0115) 2007; 179
Hatipoglu (10.1016/j.cellimm.2015.02.008_b0190) 2014
Tada (10.1016/j.cellimm.2015.02.008_b0020) 2012; 41
Qiu (10.1016/j.cellimm.2015.02.008_b0065) 2011; 17
Ju (10.1016/j.cellimm.2015.02.008_b0120) 2009; 21
Szabo (10.1016/j.cellimm.2015.02.008_b0240) 2013; 8
22971679 - Int J Oncol. 2012 Nov;41(5):1601-9
22171902 - Int J Clin Pract. 2012 Jan;66(1):21-7
17785785 - J Immunol. 2007 Sep 15;179(6):3515-23
25148301 - Viral Immunol. 2014 Oct;27(8):412-7
18980227 - Hepatology. 2009 Jan;49(1):124-32
22193102 - Nature. 2011 Dec 22;480(7378):480-9
15629508 - J Hepatol. 2005 Jan;42(1):61-7
14512536 - J Virol. 2003 Oct;77(20):10862-71
22798683 - J Immunol. 2012 Aug 15;189(4):1708-16
22219594 - World J Gastroenterol. 2011 Dec 28;17(48):5260-6
19818956 - Cell Immunol. 2009;260(1):56-62
19524453 - Semin Immunol. 2009 Oct;21(5):265-72
15471553 - Cancer Sci. 2004 Sep;95(9):697-703
23405128 - PLoS One. 2013;8(2):e55264
24409494 - Gastroenterology. 2013 Dec;145(6):1481-4
16675576 - Clin Cancer Res. 2006 May 1;12(9):2817-25
15771565 - Annu Rev Immunol. 2005;23:23-68
16469329 - J Immunol Methods. 2006 Mar 20;310(1-2):40-52
20498356 - J Immunol. 2010 Jul 1;185(1):698-708
12682236 - J Immunol. 2003 Apr 15;170(8):4069-76
19684160 - Int Immunol. 2009 Oct;21(10):1135-44
17982106 - J Immunol. 2007 Nov 15;179(10):7137-46
18194173 - J Viral Hepat. 2008 Mar;15(3):219-28
16893500 - Cell Mol Immunol. 2006 Jun;3(3):197-203
18431362 - Mol Ther. 2008 Jun;16(6):1170-80
15501973 - Clin Cancer Res. 2004 Oct 15;10(20):6946-55
25150150 - Immunobiology. 2014 Dec;219(12):944-9
23442593 - Hum Vaccin Immunother. 2013 Jan;9(1):210-2
24747241 - Exp Mol Pathol. 2014 Jun;96(3):382-92
15992809 - J Immunol Methods. 2005 Jul;302(1-2):145-55
10228041 - J Immunol. 1999 May 1;162(9):5584-91
23842750 - J Immunol. 2013 Aug 15;191(4):1976-83
11905707 - Lancet Oncol. 2001 Sep;2(9):533-43
18234800 - J Virol. 2008 Apr;82(7):3561-73
23825037 - Int J Cancer. 2014 Jan 15;134(2):342-51
17522860 - Cancer Immunol Immunother. 2007 Dec;56(12):1931-43
17608923 - BMC Cancer. 2007;7:119
21087443 - Clin Exp Immunol. 2011 Feb;163(2):165-77
23108304 - Dig Dis. 2012;30(5):483-91
10453947 - J Hepatol. 1999 Aug;31(2):323-31
16729298 - Hepatology. 2006 Jun;43(6):1303-10
15166660 - Alcohol Clin Exp Res. 2004 May;28(5):824-8
9570527 - J Immunol. 1998 Feb 1;160(3):1139-47
23998316 - Liver Int. 2014 Mar;34(3):447-61
21969837 - Clin Dev Immunol. 2011;2011:249281
12824825 - Alcohol Clin Exp Res. 2003 Jun;27(6):1023-31
11159892 - Gastroenterology. 2001 Feb;120(2):512-24
14525790 - Blood. 2004 Feb 1;103(3):1026-9
17878324 - J Immunol. 2007 Oct 1;179(7):4307-12
11342445 - Blood. 2001 May 15;97(10):3171-6
12649744 - Cancer Immunol Immunother. 2003 Mar;52(3):155-61
21419713 - Clin Immunol. 2011 Jun;139(3):302-13
References_xml – volume: 191
  start-page: 1976
  year: 2013
  end-page: 1983
  ident: b0245
  article-title: Modulation of regulatory T cell function by monocyte-derived dendritic cells matured through electroporation with mRNA encoding CD40 ligand, constitutively active TLR4, and CD70
  publication-title: J. Immunol.
– volume: 97
  start-page: 3171
  year: 2001
  end-page: 3176
  ident: b0150
  article-title: Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection
  publication-title: Blood
– volume: 2011
  start-page: 249281
  year: 2011
  ident: b0145
  article-title: Dendritic cell-based vaccines positively impact natural killer and regulatory T cells in hepatocellular carcinoma patients
  publication-title: Clin. Dev. Immunol.
– volume: 179
  start-page: 7137
  year: 2007
  end-page: 7146
  ident: b0215
  article-title: Extracellular branched-chain amino acids, especially valine, regulate maturation and function of monocyte-derived dendritic cells
  publication-title: J. Immunol.
– reference: Y. Xu, H. Li, R. L. Gao, O. Adeyemo, M. Itkin and D. E. Kaplan, Expansion of interferon-gamma-producing multifunctional CD4+ T-cells and dysfunctional CD8+ T-cells by glypican-3 peptide library in hepatocellular carcinoma patients, Clin Immunol. In press (2011).
– volume: 27
  start-page: 1023
  year: 2003
  end-page: 1031
  ident: b0170
  article-title: Additive inhibition of dendritic cell allostimulatory capacity by alcohol and hepatitis C is not restored by DC maturation and involves abnormal IL-10 and IL-2 induction
  publication-title: Alcohol. Clin. Exp. Res.
– volume: 2
  start-page: 533
  year: 2001
  end-page: 543
  ident: b0005
  article-title: Global cancer statistics in the year 2000
  publication-title: Lancet Oncol.
– volume: 179
  start-page: 4307
  year: 2007
  end-page: 4312
  ident: b0130
  article-title: A new class of reverse signaling costimulators belongs to the TNF family
  publication-title: J. Immunol.
– volume: 16
  start-page: 1170
  year: 2008
  end-page: 1180
  ident: b0250
  article-title: Enhancing the T-cell stimulatory capacity of human dendritic cells by co-electroporation with CD40L, CD70 and constitutively active TLR4 encoding mRNA
  publication-title: Mol. Ther.
– volume: 163
  start-page: 165
  year: 2011
  end-page: 177
  ident: b0070
  article-title: Prolonged recurrence-free survival following OK432-stimulated dendritic cell transfer into hepatocellular carcinoma during transarterial embolization
  publication-title: Clin. Exp. Immunol.
– volume: 77
  start-page: 10862
  year: 2003
  end-page: 10871
  ident: b0155
  article-title: Hepatitis C virus structural proteins impair dendritic cell maturation and inhibit in vivo induction of cellular immune responses
  publication-title: J. Virol.
– volume: 21
  start-page: 265
  year: 2009
  end-page: 272
  ident: b0135
  article-title: The role of CD40 and CD154/CD40L in dendritic cells
  publication-title: Semin. Immunol.
– volume: 12
  start-page: 2817
  year: 2006
  end-page: 2825
  ident: b0015
  article-title: A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four alpha-fetoprotein peptides
  publication-title: Clin. Cancer Res.
– volume: 95
  start-page: 697
  year: 2004
  end-page: 703
  ident: b0030
  article-title: The critical role of type-1 innate and acquired immunity in tumor immunotherapy
  publication-title: Cancer Sci.
– volume: 3
  start-page: 197
  year: 2006
  end-page: 203
  ident: b0140
  article-title: Dendritic cell as therapeutic vaccines against tumors and its role in therapy for hepatocellular carcinoma
  publication-title: Cell. Mol. Immunol.
– volume: 49
  start-page: 124
  year: 2009
  end-page: 132
  ident: b0075
  article-title: A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma
  publication-title: Hepatology
– volume: 145
  start-page: 1481
  year: 2013
  end-page: 1484
  ident: b0255
  article-title: Activated intestinal macrophages in patients with cirrhosis release NO and IL-6 that may disrupt intestinal barrier function
  publication-title: Gastroenterology
– volume: 28
  start-page: 824
  year: 2004
  end-page: 828
  ident: b0200
  article-title: Acute alcohol consumption inhibits accessory cell function of monocytes and dendritic cells
  publication-title: Alcohol. Clin. Exp. Res.
– volume: 96
  start-page: 382
  year: 2014
  end-page: 392
  ident: b0260
  article-title: M1- and M2-macrophage polarization in rat liver cirrhosis induced by thioacetamide (TAA), focusing on Iba1 and galectin-3
  publication-title: Exp. Mol. Pathol.
– volume: 23
  start-page: 23
  year: 2005
  end-page: 68
  ident: b0125
  article-title: TNF/TNFR family members in costimulation of T cell responses
  publication-title: Annu. Rev. Immunol.
– year: 2014
  ident: b0190
  article-title: Hepatitis B virus e antigen (HBeAg) may have a negative effect on dendritic cell generation
  publication-title: Immunobiology
– volume: 52
  start-page: 155
  year: 2003
  end-page: 161
  ident: b0025
  article-title: A phase I study of autologous dendritic cell-based immunotherapy for patients with unresectable primary liver cancer
  publication-title: Cancer Immunol. Immunother.
– volume: 41
  start-page: 1601
  year: 2012
  end-page: 1609
  ident: b0020
  article-title: Phase I/II study of immunotherapy using tumor antigen-pulsed dendritic cells in patients with hepatocellular carcinoma
  publication-title: Int. J. Oncol.
– volume: 82
  start-page: 3561
  year: 2008
  end-page: 3573
  ident: b0220
  article-title: Efficient in vitro expansion of human immunodeficiency virus (HIV)-specific T-cell responses by gag mRNA-electroporated dendritic cells from treated and untreated HIV type 1-infected individuals
  publication-title: J. Virol.
– reference: A. Vogt, E. Sievers, V. Lukacs-Kornek, G. Decker, E. Raskopf, N. Meumann, H. Buning, T. Sauerbruch, C.P. Strassburg, I.G. Schmidt-Wolf and M.A. Gonzalez-Carmona, Improving immunotherapy of hepatocellular carcinoma (HCC) using dendritic cells (DC) engineered to express IL-12 in vivo, Liver Int. (2013).
– volume: 134
  start-page: 342
  year: 2014
  end-page: 351
  ident: b0050
  article-title: Combination of radiofrequency ablation and sequential cellular immunotherapy improves progression-free survival for patients with hepatocellular carcinoma
  publication-title: Int. J. Cancer
– volume: 103
  start-page: 1026
  year: 2004
  end-page: 1029
  ident: b0175
  article-title: Presence of functional dendritic cells in patients chronically infected with hepatitis C virus
  publication-title: Blood
– volume: 17
  start-page: 5260
  year: 2011
  end-page: 5266
  ident: b0065
  article-title: Hepatocellular carcinoma-specific immunotherapy with synthesized alpha1,3-galactosyl epitope-pulsed dendritic cells and cytokine-induced killer cells
  publication-title: World J. Gastroenterol.
– volume: 10
  start-page: 6946
  year: 2004
  end-page: 6955
  ident: b0040
  article-title: The spontaneous CD8+ T-cell response to HLA-A2-restricted NY-ESO-1b peptide in hepatocellular carcinoma patients
  publication-title: Clin. Cancer Res.
– volume: 260
  start-page: 56
  year: 2009
  end-page: 62
  ident: b0095
  article-title: Fast generation of dendritic cells
  publication-title: Cell. Immunol.
– volume: 21
  start-page: 1135
  year: 2009
  end-page: 1144
  ident: b0120
  article-title: A novel approach to induce human DCs from monocytes by triggering 4–1BBL reverse signaling
  publication-title: Int. Immunol.
– volume: 15
  start-page: 219
  year: 2008
  end-page: 228
  ident: b0185
  article-title: Monocyte derived dendritic cells retain their functional capacity in patients following infection with hepatitis C virus
  publication-title: J. Viral Hepatol.
– volume: 8
  start-page: e55264
  year: 2013
  ident: b0240
  article-title: The two-component adjuvant IC31(R) boosts type i interferon production of human monocyte-derived dendritic cells via ligation of endosomal TLRs
  publication-title: PLoS ONE
– volume: 480
  start-page: 480
  year: 2011
  end-page: 489
  ident: b0035
  article-title: Cancer immunotherapy comes of age
  publication-title: Nature
– volume: 179
  start-page: 3515
  year: 2007
  end-page: 3523
  ident: b0115
  article-title: Dendritic cell expression of OX40 ligand acts as a costimulatory, not polarizing, signal for optimal Th2 priming and memory induction in vivo
  publication-title: J. Immunol.
– volume: 160
  start-page: 1139
  year: 1998
  end-page: 1147
  ident: b0235
  article-title: Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: enhancement by cotransfection of genes encoding the Th1-biasing cytokines IL-12 and IFN-alpha
  publication-title: J. Immunol.
– volume: 66
  start-page: 21
  year: 2012
  end-page: 27
  ident: b0060
  article-title: Adoptive immunotherapy for postoperative hepatocellular carcinoma: a systematic review
  publication-title: Int. J. Clin. Pract.
– volume: 185
  start-page: 698
  year: 2010
  end-page: 708
  ident: b0230
  article-title: Intratumoral neoadjuvant immunotherapy using IL-12 and dendritic cells is an effective strategy to control recurrence of murine hepatocellular carcinoma in immunosuppressed mice
  publication-title: J. Immunol.
– volume: 9
  start-page: 210
  year: 2013
  end-page: 212
  ident: b0055
  article-title: Peptide vaccines for hepatocellular carcinoma
  publication-title: Hum. vaccines immunother.
– volume: 310
  start-page: 40
  year: 2006
  end-page: 52
  ident: b0205
  article-title: In vitro methods for generating CD8+ T-cell clones for immunotherapy from the naive repertoire
  publication-title: J. Immunol. Methods
– year: 2014
  ident: b0195
  article-title: Co-incubation with core proteins of HBV and HCV leads to modulation of human dendritic cells
  publication-title: Viral Immunol.
– volume: 30
  start-page: 483
  year: 2012
  end-page: 491
  ident: b0090
  article-title: Cellular immune responses to hepatocellular carcinoma: lessons for immunotherapy
  publication-title: Dig. Dis.
– volume: 43
  start-page: 1303
  year: 2006
  end-page: 1310
  ident: b0010
  article-title: The natural history of compensated cirrhosis due to hepatitis C virus: a 17-year cohort study of 214 patients
  publication-title: Hepatology
– volume: 7
  start-page: 119
  year: 2007
  ident: b0210
  article-title: A full scale comparative study of methods for generation of functional dendritic cells for use as cancer vaccines
  publication-title: BMC Cancer
– volume: 56
  start-page: 1931
  year: 2007
  end-page: 1943
  ident: b0045
  article-title: Spontaneous and vaccine induced AFP-specific T cell phenotypes in subjects with AFP-positive hepatocellular cancer
  publication-title: Cancer Immunol. Immunother.
– volume: 31
  start-page: 323
  year: 1999
  end-page: 331
  ident: b0080
  article-title: Dendritic cells with immature phenotype and defective function in the peripheral blood from patients with hepatocellular carcinoma
  publication-title: J. Hepatol.
– volume: 170
  start-page: 4069
  year: 2003
  end-page: 4076
  ident: b0100
  article-title: Mature dendritic cells derived from human monocytes within 48 hours: a novel strategy for dendritic cell differentiation from blood precursors
  publication-title: J. Immunol.
– volume: 120
  start-page: 512
  year: 2001
  end-page: 524
  ident: b0165
  article-title: Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection
  publication-title: Gastroenterology
– volume: 302
  start-page: 145
  year: 2005
  end-page: 155
  ident: b0105
  article-title: FastDC derived from human monocytes within 48 h effectively prime tumor antigen-specific cytotoxic T cells
  publication-title: J. Immunol. Methods
– volume: 42
  start-page: 61
  year: 2005
  end-page: 67
  ident: b0180
  article-title: Comparable functions of plasmacytoid and monocyte-derived dendritic cells in chronic hepatitis C patients and healthy donors
  publication-title: J. Hepatol.
– volume: 189
  start-page: 1708
  year: 2012
  end-page: 1716
  ident: b0110
  article-title: Differential requirement for CD70 and CD80/CD86 in dendritic cell-mediated activation of tumor-tolerized CD8 T cells
  publication-title: J. Immunol.
– volume: 162
  start-page: 5584
  year: 1999
  end-page: 5591
  ident: b0160
  article-title: Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals
  publication-title: J. Immunol.
– volume: 10
  start-page: 6946
  year: 2004
  ident: 10.1016/j.cellimm.2015.02.008_b0040
  article-title: The spontaneous CD8+ T-cell response to HLA-A2-restricted NY-ESO-1b peptide in hepatocellular carcinoma patients
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-04-0502
– volume: 302
  start-page: 145
  year: 2005
  ident: 10.1016/j.cellimm.2015.02.008_b0105
  article-title: FastDC derived from human monocytes within 48 h effectively prime tumor antigen-specific cytotoxic T cells
  publication-title: J. Immunol. Methods
  doi: 10.1016/j.jim.2005.05.010
– volume: 21
  start-page: 265
  year: 2009
  ident: 10.1016/j.cellimm.2015.02.008_b0135
  article-title: The role of CD40 and CD154/CD40L in dendritic cells
  publication-title: Semin. Immunol.
  doi: 10.1016/j.smim.2009.05.010
– volume: 160
  start-page: 1139
  year: 1998
  ident: 10.1016/j.cellimm.2015.02.008_b0235
  article-title: Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: enhancement by cotransfection of genes encoding the Th1-biasing cytokines IL-12 and IFN-alpha
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.160.3.1139
– volume: 7
  start-page: 119
  year: 2007
  ident: 10.1016/j.cellimm.2015.02.008_b0210
  article-title: A full scale comparative study of methods for generation of functional dendritic cells for use as cancer vaccines
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-7-119
– volume: 189
  start-page: 1708
  year: 2012
  ident: 10.1016/j.cellimm.2015.02.008_b0110
  article-title: Differential requirement for CD70 and CD80/CD86 in dendritic cell-mediated activation of tumor-tolerized CD8 T cells
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.1201271
– volume: 16
  start-page: 1170
  year: 2008
  ident: 10.1016/j.cellimm.2015.02.008_b0250
  article-title: Enhancing the T-cell stimulatory capacity of human dendritic cells by co-electroporation with CD40L, CD70 and constitutively active TLR4 encoding mRNA
  publication-title: Mol. Ther.
  doi: 10.1038/mt.2008.77
– volume: 42
  start-page: 61
  year: 2005
  ident: 10.1016/j.cellimm.2015.02.008_b0180
  article-title: Comparable functions of plasmacytoid and monocyte-derived dendritic cells in chronic hepatitis C patients and healthy donors
  publication-title: J. Hepatol.
  doi: 10.1016/j.jhep.2004.09.014
– volume: 179
  start-page: 4307
  year: 2007
  ident: 10.1016/j.cellimm.2015.02.008_b0130
  article-title: A new class of reverse signaling costimulators belongs to the TNF family
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.179.7.4307
– volume: 49
  start-page: 124
  year: 2009
  ident: 10.1016/j.cellimm.2015.02.008_b0075
  article-title: A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma
  publication-title: Hepatology
  doi: 10.1002/hep.22626
– volume: 191
  start-page: 1976
  year: 2013
  ident: 10.1016/j.cellimm.2015.02.008_b0245
  article-title: Modulation of regulatory T cell function by monocyte-derived dendritic cells matured through electroporation with mRNA encoding CD40 ligand, constitutively active TLR4, and CD70
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.1201008
– volume: 15
  start-page: 219
  year: 2008
  ident: 10.1016/j.cellimm.2015.02.008_b0185
  article-title: Monocyte derived dendritic cells retain their functional capacity in patients following infection with hepatitis C virus
  publication-title: J. Viral Hepatol.
  doi: 10.1111/j.1365-2893.2007.00934.x
– volume: 162
  start-page: 5584
  year: 1999
  ident: 10.1016/j.cellimm.2015.02.008_b0160
  article-title: Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.162.9.5584
– volume: 82
  start-page: 3561
  year: 2008
  ident: 10.1016/j.cellimm.2015.02.008_b0220
  article-title: Efficient in vitro expansion of human immunodeficiency virus (HIV)-specific T-cell responses by gag mRNA-electroporated dendritic cells from treated and untreated HIV type 1-infected individuals
  publication-title: J. Virol.
  doi: 10.1128/JVI.02080-07
– volume: 2
  start-page: 533
  year: 2001
  ident: 10.1016/j.cellimm.2015.02.008_b0005
  article-title: Global cancer statistics in the year 2000
  publication-title: Lancet Oncol.
  doi: 10.1016/S1470-2045(01)00486-7
– volume: 163
  start-page: 165
  year: 2011
  ident: 10.1016/j.cellimm.2015.02.008_b0070
  article-title: Prolonged recurrence-free survival following OK432-stimulated dendritic cell transfer into hepatocellular carcinoma during transarterial embolization
  publication-title: Clin. Exp. Immunol.
  doi: 10.1111/j.1365-2249.2010.04246.x
– volume: 9
  start-page: 210
  year: 2013
  ident: 10.1016/j.cellimm.2015.02.008_b0055
  article-title: Peptide vaccines for hepatocellular carcinoma
  publication-title: Hum. vaccines immunother.
  doi: 10.4161/hv.22473
– volume: 3
  start-page: 197
  year: 2006
  ident: 10.1016/j.cellimm.2015.02.008_b0140
  article-title: Dendritic cell as therapeutic vaccines against tumors and its role in therapy for hepatocellular carcinoma
  publication-title: Cell. Mol. Immunol.
– volume: 95
  start-page: 697
  year: 2004
  ident: 10.1016/j.cellimm.2015.02.008_b0030
  article-title: The critical role of type-1 innate and acquired immunity in tumor immunotherapy
  publication-title: Cancer Sci.
  doi: 10.1111/j.1349-7006.2004.tb03248.x
– volume: 179
  start-page: 3515
  year: 2007
  ident: 10.1016/j.cellimm.2015.02.008_b0115
  article-title: Dendritic cell expression of OX40 ligand acts as a costimulatory, not polarizing, signal for optimal Th2 priming and memory induction in vivo
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.179.6.3515
– volume: 23
  start-page: 23
  year: 2005
  ident: 10.1016/j.cellimm.2015.02.008_b0125
  article-title: TNF/TNFR family members in costimulation of T cell responses
  publication-title: Annu. Rev. Immunol.
  doi: 10.1146/annurev.immunol.23.021704.115839
– volume: 17
  start-page: 5260
  year: 2011
  ident: 10.1016/j.cellimm.2015.02.008_b0065
  article-title: Hepatocellular carcinoma-specific immunotherapy with synthesized alpha1,3-galactosyl epitope-pulsed dendritic cells and cytokine-induced killer cells
  publication-title: World J. Gastroenterol.
  doi: 10.3748/wjg.v17.i48.5260
– volume: 134
  start-page: 342
  year: 2014
  ident: 10.1016/j.cellimm.2015.02.008_b0050
  article-title: Combination of radiofrequency ablation and sequential cellular immunotherapy improves progression-free survival for patients with hepatocellular carcinoma
  publication-title: Int. J. Cancer
  doi: 10.1002/ijc.28372
– volume: 31
  start-page: 323
  year: 1999
  ident: 10.1016/j.cellimm.2015.02.008_b0080
  article-title: Dendritic cells with immature phenotype and defective function in the peripheral blood from patients with hepatocellular carcinoma
  publication-title: J. Hepatol.
  doi: 10.1016/S0168-8278(99)80231-1
– volume: 21
  start-page: 1135
  year: 2009
  ident: 10.1016/j.cellimm.2015.02.008_b0120
  article-title: A novel approach to induce human DCs from monocytes by triggering 4–1BBL reverse signaling
  publication-title: Int. Immunol.
  doi: 10.1093/intimm/dxp077
– volume: 2011
  start-page: 249281
  year: 2011
  ident: 10.1016/j.cellimm.2015.02.008_b0145
  article-title: Dendritic cell-based vaccines positively impact natural killer and regulatory T cells in hepatocellular carcinoma patients
  publication-title: Clin. Dev. Immunol.
  doi: 10.1155/2011/249281
– year: 2014
  ident: 10.1016/j.cellimm.2015.02.008_b0195
  article-title: Co-incubation with core proteins of HBV and HCV leads to modulation of human dendritic cells
  publication-title: Viral Immunol.
  doi: 10.1089/vim.2014.0056
– volume: 185
  start-page: 698
  year: 2010
  ident: 10.1016/j.cellimm.2015.02.008_b0230
  article-title: Intratumoral neoadjuvant immunotherapy using IL-12 and dendritic cells is an effective strategy to control recurrence of murine hepatocellular carcinoma in immunosuppressed mice
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.0900187
– volume: 97
  start-page: 3171
  year: 2001
  ident: 10.1016/j.cellimm.2015.02.008_b0150
  article-title: Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection
  publication-title: Blood
  doi: 10.1182/blood.V97.10.3171
– volume: 43
  start-page: 1303
  year: 2006
  ident: 10.1016/j.cellimm.2015.02.008_b0010
  article-title: The natural history of compensated cirrhosis due to hepatitis C virus: a 17-year cohort study of 214 patients
  publication-title: Hepatology
  doi: 10.1002/hep.21176
– volume: 8
  start-page: e55264
  year: 2013
  ident: 10.1016/j.cellimm.2015.02.008_b0240
  article-title: The two-component adjuvant IC31(R) boosts type i interferon production of human monocyte-derived dendritic cells via ligation of endosomal TLRs
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0055264
– volume: 170
  start-page: 4069
  year: 2003
  ident: 10.1016/j.cellimm.2015.02.008_b0100
  article-title: Mature dendritic cells derived from human monocytes within 48 hours: a novel strategy for dendritic cell differentiation from blood precursors
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.170.8.4069
– volume: 56
  start-page: 1931
  year: 2007
  ident: 10.1016/j.cellimm.2015.02.008_b0045
  article-title: Spontaneous and vaccine induced AFP-specific T cell phenotypes in subjects with AFP-positive hepatocellular cancer
  publication-title: Cancer Immunol. Immunother.
  doi: 10.1007/s00262-007-0337-9
– volume: 103
  start-page: 1026
  year: 2004
  ident: 10.1016/j.cellimm.2015.02.008_b0175
  article-title: Presence of functional dendritic cells in patients chronically infected with hepatitis C virus
  publication-title: Blood
  doi: 10.1182/blood-2003-04-1339
– volume: 120
  start-page: 512
  year: 2001
  ident: 10.1016/j.cellimm.2015.02.008_b0165
  article-title: Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection
  publication-title: Gastroenterology
  doi: 10.1053/gast.2001.21212
– year: 2014
  ident: 10.1016/j.cellimm.2015.02.008_b0190
  article-title: Hepatitis B virus e antigen (HBeAg) may have a negative effect on dendritic cell generation
  publication-title: Immunobiology
  doi: 10.1016/j.imbio.2014.07.020
– volume: 52
  start-page: 155
  year: 2003
  ident: 10.1016/j.cellimm.2015.02.008_b0025
  article-title: A phase I study of autologous dendritic cell-based immunotherapy for patients with unresectable primary liver cancer
  publication-title: Cancer Immunol. Immunother.
  doi: 10.1007/s00262-002-0360-9
– volume: 310
  start-page: 40
  year: 2006
  ident: 10.1016/j.cellimm.2015.02.008_b0205
  article-title: In vitro methods for generating CD8+ T-cell clones for immunotherapy from the naive repertoire
  publication-title: J. Immunol. Methods
  doi: 10.1016/j.jim.2005.11.023
– volume: 27
  start-page: 1023
  year: 2003
  ident: 10.1016/j.cellimm.2015.02.008_b0170
  article-title: Additive inhibition of dendritic cell allostimulatory capacity by alcohol and hepatitis C is not restored by DC maturation and involves abnormal IL-10 and IL-2 induction
  publication-title: Alcohol. Clin. Exp. Res.
  doi: 10.1111/j.1530-0277.2003.tb04431.x
– volume: 260
  start-page: 56
  year: 2009
  ident: 10.1016/j.cellimm.2015.02.008_b0095
  article-title: Fast generation of dendritic cells
  publication-title: Cell. Immunol.
  doi: 10.1016/j.cellimm.2009.09.003
– volume: 28
  start-page: 824
  year: 2004
  ident: 10.1016/j.cellimm.2015.02.008_b0200
  article-title: Acute alcohol consumption inhibits accessory cell function of monocytes and dendritic cells
  publication-title: Alcohol. Clin. Exp. Res.
  doi: 10.1097/01.ALC.0000127104.80398.9B
– volume: 96
  start-page: 382
  year: 2014
  ident: 10.1016/j.cellimm.2015.02.008_b0260
  article-title: M1- and M2-macrophage polarization in rat liver cirrhosis induced by thioacetamide (TAA), focusing on Iba1 and galectin-3
  publication-title: Exp. Mol. Pathol.
  doi: 10.1016/j.yexmp.2014.04.003
– volume: 77
  start-page: 10862
  year: 2003
  ident: 10.1016/j.cellimm.2015.02.008_b0155
  article-title: Hepatitis C virus structural proteins impair dendritic cell maturation and inhibit in vivo induction of cellular immune responses
  publication-title: J. Virol.
  doi: 10.1128/JVI.77.20.10862-10871.2003
– ident: 10.1016/j.cellimm.2015.02.008_b0225
  doi: 10.1111/liv.12284
– volume: 179
  start-page: 7137
  year: 2007
  ident: 10.1016/j.cellimm.2015.02.008_b0215
  article-title: Extracellular branched-chain amino acids, especially valine, regulate maturation and function of monocyte-derived dendritic cells
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.179.10.7137
– volume: 30
  start-page: 483
  year: 2012
  ident: 10.1016/j.cellimm.2015.02.008_b0090
  article-title: Cellular immune responses to hepatocellular carcinoma: lessons for immunotherapy
  publication-title: Dig. Dis.
  doi: 10.1159/000341697
– ident: 10.1016/j.cellimm.2015.02.008_b0085
  doi: 10.1016/j.clim.2011.02.014
– volume: 41
  start-page: 1601
  year: 2012
  ident: 10.1016/j.cellimm.2015.02.008_b0020
  article-title: Phase I/II study of immunotherapy using tumor antigen-pulsed dendritic cells in patients with hepatocellular carcinoma
  publication-title: Int. J. Oncol.
  doi: 10.3892/ijo.2012.1626
– volume: 480
  start-page: 480
  year: 2011
  ident: 10.1016/j.cellimm.2015.02.008_b0035
  article-title: Cancer immunotherapy comes of age
  publication-title: Nature
  doi: 10.1038/nature10673
– volume: 66
  start-page: 21
  year: 2012
  ident: 10.1016/j.cellimm.2015.02.008_b0060
  article-title: Adoptive immunotherapy for postoperative hepatocellular carcinoma: a systematic review
  publication-title: Int. J. Clin. Pract.
  doi: 10.1111/j.1742-1241.2011.02814.x
– volume: 12
  start-page: 2817
  year: 2006
  ident: 10.1016/j.cellimm.2015.02.008_b0015
  article-title: A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four alpha-fetoprotein peptides
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-05-2856
– volume: 145
  start-page: 1481
  year: 2013
  ident: 10.1016/j.cellimm.2015.02.008_b0255
  article-title: Activated intestinal macrophages in patients with cirrhosis release NO and IL-6 that may disrupt intestinal barrier function
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2013.10.031
– reference: 16675576 - Clin Cancer Res. 2006 May 1;12(9):2817-25
– reference: 15992809 - J Immunol Methods. 2005 Jul;302(1-2):145-55
– reference: 11342445 - Blood. 2001 May 15;97(10):3171-6
– reference: 23442593 - Hum Vaccin Immunother. 2013 Jan;9(1):210-2
– reference: 12824825 - Alcohol Clin Exp Res. 2003 Jun;27(6):1023-31
– reference: 22171902 - Int J Clin Pract. 2012 Jan;66(1):21-7
– reference: 22798683 - J Immunol. 2012 Aug 15;189(4):1708-16
– reference: 23998316 - Liver Int. 2014 Mar;34(3):447-61
– reference: 16729298 - Hepatology. 2006 Jun;43(6):1303-10
– reference: 25150150 - Immunobiology. 2014 Dec;219(12):944-9
– reference: 12649744 - Cancer Immunol Immunother. 2003 Mar;52(3):155-61
– reference: 17878324 - J Immunol. 2007 Oct 1;179(7):4307-12
– reference: 14512536 - J Virol. 2003 Oct;77(20):10862-71
– reference: 11905707 - Lancet Oncol. 2001 Sep;2(9):533-43
– reference: 15501973 - Clin Cancer Res. 2004 Oct 15;10(20):6946-55
– reference: 23405128 - PLoS One. 2013;8(2):e55264
– reference: 10453947 - J Hepatol. 1999 Aug;31(2):323-31
– reference: 17608923 - BMC Cancer. 2007;7:119
– reference: 20498356 - J Immunol. 2010 Jul 1;185(1):698-708
– reference: 17785785 - J Immunol. 2007 Sep 15;179(6):3515-23
– reference: 17982106 - J Immunol. 2007 Nov 15;179(10):7137-46
– reference: 15166660 - Alcohol Clin Exp Res. 2004 May;28(5):824-8
– reference: 18194173 - J Viral Hepat. 2008 Mar;15(3):219-28
– reference: 16469329 - J Immunol Methods. 2006 Mar 20;310(1-2):40-52
– reference: 21969837 - Clin Dev Immunol. 2011;2011:249281
– reference: 14525790 - Blood. 2004 Feb 1;103(3):1026-9
– reference: 15771565 - Annu Rev Immunol. 2005;23:23-68
– reference: 18431362 - Mol Ther. 2008 Jun;16(6):1170-80
– reference: 21419713 - Clin Immunol. 2011 Jun;139(3):302-13
– reference: 16893500 - Cell Mol Immunol. 2006 Jun;3(3):197-203
– reference: 24747241 - Exp Mol Pathol. 2014 Jun;96(3):382-92
– reference: 9570527 - J Immunol. 1998 Feb 1;160(3):1139-47
– reference: 18234800 - J Virol. 2008 Apr;82(7):3561-73
– reference: 22971679 - Int J Oncol. 2012 Nov;41(5):1601-9
– reference: 11159892 - Gastroenterology. 2001 Feb;120(2):512-24
– reference: 23108304 - Dig Dis. 2012;30(5):483-91
– reference: 19524453 - Semin Immunol. 2009 Oct;21(5):265-72
– reference: 25148301 - Viral Immunol. 2014 Oct;27(8):412-7
– reference: 15629508 - J Hepatol. 2005 Jan;42(1):61-7
– reference: 15471553 - Cancer Sci. 2004 Sep;95(9):697-703
– reference: 24409494 - Gastroenterology. 2013 Dec;145(6):1481-4
– reference: 23842750 - J Immunol. 2013 Aug 15;191(4):1976-83
– reference: 23825037 - Int J Cancer. 2014 Jan 15;134(2):342-51
– reference: 17522860 - Cancer Immunol Immunother. 2007 Dec;56(12):1931-43
– reference: 21087443 - Clin Exp Immunol. 2011 Feb;163(2):165-77
– reference: 22219594 - World J Gastroenterol. 2011 Dec 28;17(48):5260-6
– reference: 12682236 - J Immunol. 2003 Apr 15;170(8):4069-76
– reference: 22193102 - Nature. 2011 Dec 22;480(7378):480-9
– reference: 10228041 - J Immunol. 1999 May 1;162(9):5584-91
– reference: 19684160 - Int Immunol. 2009 Oct;21(10):1135-44
– reference: 18980227 - Hepatology. 2009 Jan;49(1):124-32
– reference: 19818956 - Cell Immunol. 2009;260(1):56-62
SSID ssj0011490
Score 2.1191347
Snippet •CD14+ monocytes from cirrhotic patients displayed enhanced M1 and M2 polarization.•MoDC derived from cirrhotic CD14+ monocytes display normal co-stimulation...
Few studies have investigated the impact of liver cirrhosis on dendritic cell function. The purpose of this study was to compare the activation and...
SourceID pubmedcentral
proquest
pubmed
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 36
SubjectTerms Adult
Aged
Antigen Presentation - immunology
Cell Differentiation - immunology
Cell Proliferation
Cells, Cultured
Cirrhosis
Coculture Techniques
Dendritic cell
Dendritic Cells - immunology
Dendritic Cells - metabolism
Enzyme-Linked Immunospot Assay
Flow Cytometry
Glypican-3
Healthy Volunteers
Hepatitis C
Human
Humans
Immunophenotyping
Interferon-gamma - immunology
Interferon-gamma - metabolism
Lipopolysaccharide Receptors - immunology
Lipopolysaccharide Receptors - metabolism
Liver Cirrhosis - immunology
Liver Cirrhosis - metabolism
Liver Cirrhosis - pathology
M1 macrophage
M2 macrophage
Macrophages - classification
Macrophages - immunology
Male
Middle Aged
Monocyte
Monocytes - immunology
Monocytes - metabolism
T-Lymphocytes - immunology
T-Lymphocytes - metabolism
Title Monocyte-derived dendritic cells from cirrhotic patients retain similar capacity for maturation/activation and antigen presentation as those from healthy subjects
URI https://dx.doi.org/10.1016/j.cellimm.2015.02.008
https://www.ncbi.nlm.nih.gov/pubmed/25734547
https://www.proquest.com/docview/1674689975
https://www.proquest.com/docview/1732813857
https://pubmed.ncbi.nlm.nih.gov/PMC4405471
Volume 295
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqIhAXBOW1PCojcc1uHDuvY1VRLaD2RKXeLD-1qdhktcki7YUf01_amTjZsiCoxCGHTWzFmxnPfHHm-0zIx6QUBWeJi7iLXSRKl0QaEnMUa2W1sJ5phnzn84tsfim-XKVXB-R05MJgWeUQ-0NM76P1cGY2PM3ZqqqQ44szRJQMNf0BRSODXeTo5dOfuzIPgPthnQU_82PrOxbP7HqKi-PVEgnpLA3SncXf8tOf-PP3Mspf8tLZU_JkAJT0JIz5GTlw9RF5GLaY3B6RR-fDx_Pn5Abmb2O2nYssuN0PZynEHNtvdUBxiC1Frgk11Xq9aPDkoLnaUqxJrGraVssKXoSpgQRrAL1TALx0icqgvXlnyJEIK7xU1RaODqU-6eqO4QQXWtotmtaFewUW5pa2G43rQe0Lcnn26dvpPBq2aIgMPPUuygxnNjbCG5spH3MF-b5UiTdZZjMAL5Y7rZMchex4AvnYIKJguQZgF2vrPX9JDuumdq8JTWNllS-YSpgTvMh1qY1ODNPK5d56PSFiNIw0g345bqPxXY6FatdysKdEe8o4kWDPCZnuuq2CgMd9HYrR6nLPEyUkmfu6fhi9RMIsxRaqds2mlcj1yODVNk__0QZ1kxgv0nxCXgXP2o0YAitH6bUJyfd8btcAVcL3r9TVolcLFwDJAYG8-f-_9ZY8xl-hzPMdOezWG_ceoFinj_u5dkwenHz-Or-4BW4pOzo
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6VIigXBAVKeC4SVyde7_p1RFWrAE1PrdTbal9WXBE7ih2kXPgx_FJmvHZKqKASh1y8u8ra8_q8nvmGkI9RLjLOIhdwF7pA5C4KNATmINTKamELphnWO8_Ok-ml-HIVX-2R46EWBtMqe9_vfXrnrfsrk_5pTpZliTW-aCEiZ8jpDyj6HrkvwHyxjcH4xzbPA_C-P2jB7_w4_aaMZ3I9xtPxcoEV6Sz23J3Z3wLUbQD6Zx7lb4Hp9Al53CNK-slv-inZc9UheeB7TG4OycNZ__X8GfkJBlybTesCC3r33VkKTsd2vQ4obrGhWGxCTblazWu82JOuNhSTEsuKNuWihDdhaiDCGoDvFBAvXSA1aCffCRZJ-CNeqioLvxa5PunypsQJBhrazuvG-f_yZZgb2qw1Hgg1z8nl6cnF8TToezQEBh57GySGMxsaURibqCLkCgJ-rqLCJIlNAL1Y7rSOUmSy4xEEZIOQgqUakF2obVHwF2S_qiv3ktA4VFYVGVMRc4Jnqc610ZFhWrm0sIUeETEIRpqewBz7aHyTQ6batezlKVGeMowkyHNExttlS8_gcdeCbJC63FFFCVHmrqUfBi2RYKY4Q1WuXjcSiz0SeLdN43_MQeIkxrM4HZEjr1nbHYNn5ci9NiLpjs5tJyBN-O5IVc47unABmBwgyKv_v6335GB6MTuTZ5_Pv74mj3DE53y-Ifvtau3eAi5r9bvO7n4BQ4s8yA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Monocyte-derived+dendritic+cells+from+cirrhotic+patients+retain+similar+capacity+for+maturation%2Factivation+and+antigen+presentation+as+those+from+healthy+subjects&rft.jtitle=Cellular+immunology&rft.au=Tanoue%2C+Shiroh&rft.au=Chang%2C+Li-Yuan&rft.au=Li%2C+Yonghai&rft.au=Kaplan%2C+David+E&rft.date=2015-05-01&rft.issn=0008-8749&rft.volume=295&rft.issue=1&rft.spage=36&rft.epage=45&rft_id=info:doi/10.1016%2Fj.cellimm.2015.02.008&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0008-8749&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0008-8749&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0008-8749&client=summon